Don't Just Read the News, Understand It.
Published loading...Updated

HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics

  • On May 28, 2025, the Trump administration withdrew $766 million in funding previously allocated to Massachusetts-based Moderna for the development of a bird flu vaccine.
  • The contract was awarded in January and July 2024 to support late-stage development and purchase of Moderna's mRNA-based vaccine targeting H5N1 bird flu viruses.
  • Moderna reported encouraging interim findings from a Phase 1/2 study of mRNA-1018 in 300 healthy adults, demonstrating a strong immune response along with a favorable safety profile.
  • According to a statement from HHS, further funding for Moderna’s H5N1 mRNA vaccine was deemed neither scientifically valid nor ethically appropriate due to concerns related to safety and integrity.
  • The contract termination adds uncertainty to pandemic vaccine preparedness, while Moderna said it will explore alternative development paths for the bird flu vaccine.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

334 Articles

All
Left
49
Center
162
Right
33
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 66% of the sources are Center
66% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KGW 8 broke the news in Portland, United States on Wednesday, May 28, 2025.
Sources are mostly out of (0)